Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia

Satoshi Tsukada, Douglas C. Saffran, David J. Rawlings, Ornella Parolini, R. Cutler Allen, Ivana Klisak, Robert S. Sparkes, Hiromi Kubagawa, Thuluvancheri Mohandas, Shirley Quan, John W. Belmont, Max D. Cooper, Mary Ellen Conley, Owen N. Witte

Research output: Contribution to journalArticlepeer-review

1234 Scopus citations

Abstract

We describe a novel cytoplasmic tyrosine kinase, termed BPK (B cell progenitor kinase), which is expressed in all stages of the B lineage and in myeloid cells. BPK has classic SH1, SH2, and SH3 domains, but lacks myristylation signals and a regulatory phosphorylation site corresponding to tyrosine 527 of c-src. BPK has a long, basic amino-terminal region upstream of the SH3 domain. BPK was evaluated as a candidate for human X-linked agammaglobulinemia (XLA), an inherited immunodeficiency characterized by a severe deficit of B and plasma cells and profound hypogammaglobulinemia. BPK mapped to within 100 kb of a probe defining the polymorphism most closely linked to XLA at DXS178. Reduction in or the absence of BPK mRNA, protein expression, and kinase activity was observed in XLA pre-B and B cell lines. BPK is likely the XLA gene and functions in pathways critical to B cell expansion.

Original languageEnglish (US)
Pages (from-to)279-290
Number of pages12
JournalCell
Volume72
Issue number2
DOIs
StatePublished - Jan 29 1993

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia'. Together they form a unique fingerprint.

Cite this